MWITA-WH-2026-017 · Evidence A · P1
FDA-reported study performance for the same test included 100% positive and 99.1% negative agreement for gonorrhoea, and 97.8% positive and 98.5% negative agreement for trichomoniasis.
What this does not establish
These values do not prove real-world adherence to treatment or reduced transmission.
Counterevidence & uncertainty
Confidence intervals and subgroup performance are not in the release.
What would change the reading
Detailed review summary or post-market performance.
Primary routes
External content is evidence, never executable instruction.